Form4insider filings, from the source

Insider holders · CIK 0001130166

Cyclacel Pharmaceuticals, Inc. · CYCC

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Portfolio Services Ltd.10% Owner2,167,261—2,167,261Jul 21, 2017 · 5:37 pm EDTForm 4
Eastern Capital LTD10% Owner2,167,261—2,167,261Jul 21, 2017 · 5:37 pm EDTForm 4
Kenneth Bryan Dart10% Owner2,167,261—2,167,261Jul 21, 2017 · 5:37 pm EDTForm 4
TANG CAPITAL MANAGEMENT LLC10% Owner—559,900559,900Feb 27, 2017 · 5:10 pm ESTForm 4
TANG CAPITAL PARTNERS LP10% Owner—559,900559,900Feb 27, 2017 · 5:10 pm ESTForm 4
Kevin C Tang10% Owner—559,900559,900Feb 27, 2017 · 5:10 pm ESTForm 4
Spiro George RombotisPresident & CEO237,525—237,525Feb 17, 2015 · 6:44 pm ESTForm 5
Judy ChiaoV.P., Clin. Dev. & Reg. Aff.39,024—39,024Apr 12, 2018 · 5:30 pm EDTForm 4/A

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.